| 000 | 01892nam a2200301Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625160156.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-16725 | ||
| 245 | 1 | 0 | _aCRISPR/Cas9-Based Engineering of the Epigenome |
| 490 | 0 | _vCell Stem Cell, 21(4), p.431-447, 2017 | |
| 520 | 3 | _aDetermining causal relationships between distinct chromatin features and gene expression, and ultimately cell behavior, remains a major challenge. Recent developments in targetable epigenome-editing tools enable us to assign direct transcriptional and functional consequences to locus-specific chromatin modifications. This Protocol Review discusses the unprecedented opportunity that CRISPR/Cas9 technology offers for investigating and manipulating the epigenome to facilitate further understanding of stem cell biology and engineering of stem cells for therapeutic applications. We also provide technical considerations for standardization and further improvement of the CRISPR/Cas9-based tools to engineer the epigenome. Pulecio et al. discuss opportunities that CRISPR/Cas9 technology offers for investigating and manipulating the stem cell epigenome and also provide technical considerations for CRISPR/Cas9 tool standardization and improvement. | |
| 650 | 1 | 4 | _aCHROMATIN ARCHITECTURE |
| 650 | 1 | 4 | _aCRISPR-DCAS9 |
| 650 | 1 | 4 | _aDNA METHYLATION |
| 650 | 1 | 4 | _aHISTONE MODIFICATIONS |
| 650 | 1 | 4 | _aTARGETED EPIGENOME ENGINEERING |
| 650 | 1 | 4 | _aTARGETED GENE EDITION |
| 650 | 1 | 4 | _aTRANSCRIPTIONAL REGULATION |
| 700 | 1 | 2 | _aPulecio, J. |
| 700 | 1 | 2 | _aVerma, N. |
| 700 | 1 | 2 | _aMejía-Ramírez, E. |
| 700 | 1 | 2 | _aHuangfu, D. |
| 700 | 1 | 2 | _aRaya, A. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1l-BWzjRzu5kw0dUsVT6H0tBDuwqkBe6Y/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c50892 _d50892 |
||